{"id":"contrast-enhanced-ultrasound-using-lumason","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Flushing"},{"rate":null,"effect":"Chest discomfort"},{"rate":null,"effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lumason consists of sulfur hexafluoride microbubbles stabilized by a lipid shell. When injected intravenously, these microbubbles circulate through the vasculature and strongly reflect ultrasound waves, creating enhanced contrast in real-time imaging. This allows clinicians to better visualize perfusion patterns, detect abnormalities in blood flow, and improve diagnostic accuracy in cardiac, hepatic, and other organ imaging.","oneSentence":"Lumason is a microbubble contrast agent that enhances ultrasound imaging by reflecting sound waves, improving visualization of blood flow and tissue perfusion.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:31:08.078Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contrast-enhanced ultrasound imaging for left ventricular opacification and endocardial border definition"},{"name":"Hepatic lesion characterization and detection"},{"name":"Pediatric cardiac and abdominal imaging"}]},"trialDetails":[{"nctId":"NCT06693752","phase":"PHASE2","title":"CEUS Evaluation of Hydrocephalus in Neonates and Infants","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2026-03-31","conditions":"Hydrocephalus in Infants, Hydrocephalus Acquired","enrollment":20},{"nctId":"NCT06171607","phase":"PHASE1","title":"Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2020-11-05","conditions":"Breast Carcinoma","enrollment":100},{"nctId":"NCT03473249","phase":"PHASE4","title":"Effectiveness of Contrast-Enhanced Ultrasound","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2018-05-09","conditions":"Abdominal Injuries, Physical Abuse, Accidental Fall","enrollment":120},{"nctId":"NCT02911714","phase":"PHASE1","title":"Contrast-Enhanced Ultrasound for Kidney Transplant","status":"TERMINATED","sponsor":"University of Utah","startDate":"2018-02-21","conditions":"Kidney Transplantation","enrollment":20},{"nctId":"NCT07145801","phase":"PHASE2","title":"Y-90 Treatment Response Using Transarterial Radioembolization","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-09-11","conditions":"HCC, Hepatocellular Carcinoma, Liver Cancer","enrollment":30},{"nctId":"NCT05206942","phase":"NA","title":"Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-03-21","conditions":"Solid Tumor","enrollment":30},{"nctId":"NCT03549520","phase":"PHASE3","title":"CEUS Evaluation of Hypoxic Ischemic Injury","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-12-01","conditions":"Hypoxic-Ischemic Encephalopathy, Brain Ischemia Hypoxia","enrollment":1},{"nctId":"NCT03107520","phase":"EARLY_PHASE1","title":"Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2017-05-22","conditions":"Developmental Dysplasia of the Hip","enrollment":125},{"nctId":"NCT03549507","phase":"PHASE3","title":"CEUS Evaluation of Bowel Perfusion in Necrotizing Enterocolitis","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-11-04","conditions":"Necrotizing Enterocolitis of Newborn, Bowel Ischemic","enrollment":1},{"nctId":"NCT05025449","phase":"PHASE4","title":"BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury","status":"COMPLETED","sponsor":"Emory University","startDate":"2021-09-30","conditions":"Abdominal Trauma","enrollment":267},{"nctId":"NCT04640038","phase":"PHASE3","title":"Contrast Enhanced Ultrasound in COVID-19","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-12-18","conditions":"Covid19, Multisystem Inflammatory Syndrome in Children (MIS-C)","enrollment":4},{"nctId":"NCT03907657","phase":"PHASE2","title":"Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2019-09-23","conditions":"Von-Hippel Lindau, Kidney Disease, Chronic","enrollment":15},{"nctId":"NCT04021238","phase":"PHASE2","title":"Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2020-10-07","conditions":"Kidney Cancer","enrollment":25},{"nctId":"NCT03653702","phase":"PHASE1","title":"Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)","status":"UNKNOWN","sponsor":"Boston Children's Hospital","startDate":"2023-10-01","conditions":"Vesico-Ureteral Reflux","enrollment":70},{"nctId":"NCT04150874","phase":"EARLY_PHASE1","title":"Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2020-02-19","conditions":"Hepatocellular Carcinoma, Liver Cancer","enrollment":4},{"nctId":"NCT03335033","phase":"PHASE2","title":"New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-11-15","conditions":"Carotid Artery Plaque","enrollment":54},{"nctId":"NCT03335020","phase":"PHASE1","title":"Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2018-04-01","conditions":"Fibromuscular Dysplasia of Arteries, Segmental Arterial Mediolysis, Spontaneous Coronary Artery Dissection","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":49,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["SonoVue (25 mg under sulfur hexafluoride gas) / Lumason","Sulfur hexafluoride microbubbles for injection","US Patent No. 5,686,060"],"phase":"marketed","status":"active","brandName":"Contrast-Enhanced Ultrasound using Lumason","genericName":"Contrast-Enhanced Ultrasound using Lumason","companyName":"Children's Hospital of Philadelphia","companyId":"children-s-hospital-of-philadelphia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lumason is a microbubble contrast agent that enhances ultrasound imaging by reflecting sound waves, improving visualization of blood flow and tissue perfusion. Used for Contrast-enhanced ultrasound imaging for left ventricular opacification and endocardial border definition, Hepatic lesion characterization and detection, Pediatric cardiac and abdominal imaging.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}